Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
3.700
-0.330 (-8.19%)
At close: Dec 5, 2025, 4:00 PM EST
3.810
+0.110 (2.97%)
After-hours: Dec 5, 2025, 7:55 PM EST
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
2.82M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
AEMD News
- 1 day ago - Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million - PRNewsWire
- 4 days ago - Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs - PRNewsWire
- 23 days ago - Aethlon Medical, Inc. (AEMD) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update - PRNewsWire
- 4 weeks ago - Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025 - PRNewsWire
- 2 months ago - Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial - PRNewsWire
- 3 months ago - Aethlon Medical Announces Pricing of $4.5 Million Public Offering - PRNewsWire
- 3 months ago - Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC) - PRNewsWire